Keros Therapeutics Inc.

NASDAQ: KROS · Real-Time Price · USD
14.46
0.04 (0.28%)
At close: Aug 15, 2025, 3:59 PM
14.08
-2.66%
After-hours: Aug 15, 2025, 05:42 PM EDT

Keros Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-187.35M -152.99M -104.68M -58.74M
Depreciation & Amortization
1.23M 815K 674K 378K
Stock-Based Compensation
34.87M 28.76M 18.68M 11.72M
Other Working Capital
-8.59M 384K -3.28M -597K
Other Non-Cash Items
1.82M 1.56M 953K 520K
Deferred Income Tax
n/a n/a n/a 46K
Change in Working Capital
-11.44M -2.65M 14.31M -16.07M
Operating Cash Flow
-160.87M -124.51M -70.06M -62.15M
Capital Expenditures
-1.93M -2.46M -1.24M -1.02M
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
-1.93M -2.46M -1.24M -1.02M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
11.69M 3.13M 731K 379K
Financial Cash Flow
391.82M 178.96M 120.31M 28.55M
Net Cash Flow
229.02M 51.98M 49.01M -34.62M
Free Cash Flow
-162.8M -126.97M -71.3M -63.17M